BenchSci

BenchSci's vision is to bring medicine to patients 50% faster by 2025. They're doing this by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, their platform accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide.